Facebook
X
LinkedIn
Forward
Insights from the 67th ASH Annual Meeting - Los Angeles
Insights from the 67th ASH Annual Meeting, an independent review of the ASH Annual Meeting, is a two-day program designed to provide the latest science and education from the world’s premier hematology event. The abstracts selected for presentation and discussion reflect the foremost research, insights, and advances in hematology that will impact clinical practice and patient care.
The program features in-depth discussions and analyses of the latest scientific findings in blood disorders and cancers, as well as practice-changing advances in treatment. Expert faculty will review the findings, discuss their potential impact on the current standard of care, and apply the results within the clinical context of a patient case.
Intended Learners
The educational activity is intended for hematologists/oncologists, medical oncologists, oncology NPs/PAs, pharmacists, nurses, and other healthcare professionals who treat patients with hematologic disorders.
Learning Objectives
After attending the Insights from the 67th ASH Annual Meeting, learners should be able to :
1. Assess the latest data on the treatment of hematologic disorders
2. Apply recent clinical advances to optimize outcomes in patients with hematologic disorders
3. Discuss current challenges and controversies in the management of hematologic disorders
4. Review the latest data on cellular therapies for the treatment of hematologic disorders
5. Identify best practices for the management of complex cases involving patients with hematologic disorders
Designation | Early Bird | Advanced | General Registration |
| Physicians | $100 | $125 | $175 |
Pharmacists | $75 | $100 | $150 |
NPs, PAs | $75 | $100 | $150 |
| RNs, and others | $50 | $75 | $125 |
Pharma / Med Device Company Employee** | $500 | $525 | $575 |
Students & Fellows* | $Free* | ||
REFUND POLICY
Refunds of 50% of the registration fee will be provided if you cancel up to 30 days before Insights from the 67th ASH Annual Meeting - Los Angeles commences. There are no refunds for cancellations within the 30-day window of the start of the event. To request a refund, please email [email protected]
*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession. If you would like to attend as a Student, please contact [email protected] for further information.
**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).
Presented By
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
All Times Listed are for the Pacific Standard Time Zone
Saturday, January 31, 2026 | |
| 7:00am | Check-in & Breakfast Available in Exhibit Hall |
| 7:55am | Horizon CME App Overview and CE Housekeeping |
| 8:00am | Welcome and Introductions |
| 8:05am | (01) Myelodysplastic Syndromes » Brian Ball, MD - Assistant Professor | Division of Leukemia | Department of Hematology and HCT | City of Hope National Medical Center | Duarte, CA |
| 8:35am | (02) Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia » TBA |
| 9:05am | (03) ITP/TTP, Immune Hemolysis, and aHUS » Ilene C. Weitz, MD - Professor of Medicine | Keck School of Medicine | University of Southern California | Los Angeles, CA |
| 9:35am | (04) Stump the Faculty Q+A » Faculty for Sessions (01) - (03) |
| 9:50am | Information About the Cancer Charities & Trivia For Charity Break |
| 9:55am | Break - Trivia for Charity in the Exhibit Hall |
| 10:20am | (05) Venous Thromboembolism/Anticoagulation and Its Reversal » TBA |
| 10:50am | (06) Sickle Cell Disease: Sickling and other Hemoglobinopathies » Zahra Pakbaz, MD - Associate Clinical Professor, Medicine | School of Medicine | University of California, Irvine | Orange, CA |
| 11:20am | (07) Transfusion Medicine and Apheresis » Dawn Ward, MD - Medical Director, Human Gene and Cell Therapy Facility | Medical Director, Blood and Platelet Center | Associate Clinical Professor, Pathology and Laboratory Medicine | UCLA David Geffen School of Medicine | Los Angeles, CA |
| 11:50am | (08) Stump the Faculty Q+A » Faculty for Sessions (05) - (07) |
| 12:05pm | Gather for Lunch |
| 12:10pm | Buffet Lunch Non-CME/CE Presentation Sponsored byTBA » TBA |
| 12:55pm | Dessert Break in Exhibit Hall |
| 1:10pm | (09) Acute Lymphoblastic Leukemia » TBA |
| 1:40pm | (10) Acute Myeloid Leukemia » Gary J. Schiller, MD - Professor of Medicine | Division of Hematology/Oncology | David Geffen UCLA School of Medicine | Los Angeles, California |
| 2:10pm | (11) CLL » Michael Choi, MD - HS Clinical Professor | UC San Diego Sanford Stem Cell Institute | UCSD Moores Cancer Center | UCSD Division of Hematology/Oncology | San Diego, CA |
| 2:40pm | (12) Stump the Faculty Q+A » Faculty from Sessions (09) - (11) |
| 2:55pm | Break in Exhibit Hall |
| 3:10pm | (13) Hematopoietic Stem Cell Biology » John P. Chute, MD - Linda Ostrowski Chair in Hematology/Oncology Chief | Division of Hematology and Cellular Therapy Director | Myelodysplastic Diseases Research Center Associate Director | Regenerative Medicine Institute | Cedars-Sinai | Los Angeles, CA |
| 3:45pm | (14) Hematopoietic Stem Cell Transplantation » Monzr M. Al Malki, MD - Associate Professor Department of Hematology and HCT | Director, Unrelated Donor BMT Program | Director, Haploidentical Transplant Program | City of Hope National Medical Center | Duarte, CA |
| 4:15pm | (15) Stump the Faculty Q+A » Faculty from Sessions (11) - (12) |
| 4:30pm | (16) Tackling the Difficult Cases » Conor Buckley, MD - UCLA |
| 5:00pm | Networking Reception - Exhibit Hall |
Sunday, February 1, 2026 | |
| 7:00am | Check-in & Breakfast Available in Exhibit Hall |
| 7:35am | Horizon CME App Overview and CE Housekeeping |
| 7:40am | Welcome and Introductions |
| 7:50am | (17) Low Grade Lymphoma » Marin Xavier, MD - Medical Director, Clinical Professor of Medicine | Scripps Cancer Center | Scripps Mercy Hospital | San Diego, CA |
| 8:20am | Gather for Breakfast |
| 8:25am | Breakfast Buffet Non-CME/CE Presentation Sponsored by TBA » TBA |
| 9:15m | Transition Break |
| 9:25am | (18) High Grade Lymphoma » Elizabeth Brem, MD - Associate Clinical Professor | Division of Hematology/Oncology, School of Medicine | University of California, Irvine | Orange, CA |
| 9:55m | Break - Refreshments in Exhibit Hall |
| 10:20am | (19) Myeloma & Plasma Cell Dyscrasia » Ann Mohrbacher, MD - Associate Professor of Clinical Medicine | Medical Director, Autologous Bone Marrow Transplant | Keck School of Medicine | University of Southern California | Los Angeles, CA |
| 10:50am | (20) Stump the Faculty Q+A » Faculty from Sessions (17) - (19) |
| 11:05am | Gather for Lunch |
| 11:10am | Buffet Lunch Non-CME/CE Presentation Sponsored by TBA » TBA |
| 11:55am | Dessert Break in Exhibit Hall |
| 12:05pm | (21) Cell Therapy » Swetha Kambhampati Thiruvengadam, MD - Assistant Professor, Division of Lymphoma | Department of Hematology & Hematopoietic Cell Transplantation | City of Hope | Duarte, CA |
| 12:35pm | (22) CAR-T Cell Biology » Josh Sasine, MD, PhD - Assistant Professor of Medicine | Associate Director, CAR T and Immune Effector Cell Therapy Program | Hematology & Cellular Therapy | Samuel Oschin Cancer Center | Regenerative Medicine Institute | Cedars-Sinai Medical Center | Los Angeles CA |
| 1:05pm | (23) Stump the Faculty Q+A » Faculty from Sessions (21) - (22) |
| 1:35pm | Closing Comments |
We want to ensure that your time at the 2026 Insights from the 67th ASH Annual Meeting - Los Angeles conference is convenient and memorable. Staying at our host hotel provides a hassle-free experience and puts you at the heart of the activity surrounding the conference.
Overnight Accommodations: Dates for discounted rates: TBA
Discounted Booking Deadline: TBA
Room rate: TBA
Parking: TBA
Available Credit
- 9.75 ABIM Medical KnowledgeHorizon CME, Inc. designates this activity for a maximum of 9.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 9.75 ACPE PharmacyThe Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This conference is approved for up to 9.75 credit by the Washington State Pharmacy Association.
This activity is approved for up to 9.75 credit by the Washington State Pharmacy Association. Activity Type: Live| Start/End date: Sat, 01/31/2026 - 4:00am-Sun, 02/01/2026 - 1:35pm The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 60 days after the activity - please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile. If you encounter any CPE problems, please contact WSPA at 425- 228-7171 - 9.75 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Live activity for a maximum of 9.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 9.75 ANCCThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 9.75 credit.
- 4.25 PharmacologyThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 4.25 credit.